Innate recognition network driving herpes simplex virus-induced corneal immunopathology: Role of the toll pathway in early inflammatory events in stromal keratitis

Journal of Virology

Volumn 81, Issue 20, 2007, Pages 11128-11138

  Sarangi, Pranita P ^a   Kim, Bumseok ^b   Kurt Jones, Evelyn ^c   Rouse, Barry T ^a,d  

^a UNIVERSITY OF TENNESSEE   (United States)

^b Chonbuk National University   (South Korea)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF TENNESSEE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 9;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN RECOGNITION; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DISEASE SEVERITY; HERPES SIMPLEX KERATITIS; HERPES SIMPLEX VIRUS; INFECTION SENSITIVITY; INFLAMMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR INTRINSIC ACTIVITY; SIGNAL TRANSDUCTION; VIRUS ENCEPHALITIS; VISUAL IMPAIRMENT;

ANIMALS; CORNEAL STROMA; DISEASE SUSCEPTIBILITY; INFLAMMATION; KERATITIS; MICE; MICE, KNOCKOUT; MYELOID DIFFERENTIATION FACTOR 88; SIMPLEXVIRUS; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTOR 9;

ANIMALIA; MUS; SIMPLEXVIRUS;

EID: 35148828516     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01008-07     Document Type: Article

References (43)

1. Aravalli, R. N., S. Hu, T. N. Rowen, J. M. Palmquist, and J. R. Lokensgard. 2005. Cutting edge: TLR2-mediated proinflammatory cytokine and chemokine production by microglial cells in response to herpes simplex virus. J. Immunol. 175:4189-4193.
2. Arslan, A., and H. H. Zingg. 1996. Regulation of COX-2 gene expression in rat uterus in vivo and in vitro. Prostaglandins 52:463-481.
3. Banerjee, K., P. S. Biswas, B. Kim, S. Lee, and B. T. Rouse. 2004. CXCR2-/- mice show enhanced susceptibility to herpetic stromal keratitis: a role for IL-6-induced neovascularization. J. Immunol. 172:1237-1245.
4. Banerjee, K., S. Deshpande, M. Zheng, U. Kumaraguru, S. P. Schoenberger, and B. T. Rouse. 2002. Herpetic stromal keratitis in the absence of viral antigen recognition. Cell. Immunol. 219:108-118.
5. Beg, A. A. 2002. Endogenous ligands of Toll-like receptors: implications for regulating inflammatory and immune responses. Trends Immunol. 23:509-512.
6. Biragyn, A., P. A. Ruffini, C. A. Leifer, E. Klyushnenkova, A. Shakhov, O. Chertov, A. K. Shirakawa, J. M. Farber, D. M. Segal, J. J. Oppenheim, and L. W. Kwak. 2002. Toll-like receptor 4-dependent activation of dendritic cells by beta-defensin 2. Science 298:1025-1029.
7. Biswas, P. S., K. Banerjee, B. Kim, P. R. Kinchington, and B. T. Rouse. 2005. Role of inflammatory cytokine-induced cyclooxygenase 2 in the ocular immunopathologic disease herpetic stromal keratitis. J. Virol. 79:10589-10600.
8. Biswas, P. S., K. Banerjee, M. Zheng, and B. T. Rouse. 2004. Counteracting corneal immunoinflammatory lesion with interleukin-1 receptor antagonist protein. J. Leukoc. Biol. 76:868-875.
9. Biswas, P. S., and B. T. Rouse. 2005. Early events in HSV keratitis - setting the stage for a blinding disease. Microbes Infect. 7:799-810.
10. Boehme, K. W., and T. Compton. 2004. Innate sensing of viruses by Toll-like receptors. J. Virol. 78:7867-7873.
11. Bowman, C. C., and K. L. Bost. 2004. Cyclooxygenase-2-mediated prostaglandin E2 production in mesenteric lymph nodes and in cultured macrophages and dendritic cells after infection with Salmonella. J. Immunol. 172:2469-2475.
12. Burch, A. D., and S. K. Weller. 2004. Nuclear sequestration of cellular chaperone and proteasomal machinery during herpes simplex virus type 1 infection. J. Virol. 78:7175-7185.
13. Dana, M. R., S. N. Zhu, and J. Yamada. 1998. Topical modulation of interleukin-1 activity in corneal neovascularization. Cornea 17:403-409.
14. Deshpande, S., K. Banerjee, P. S. Biswas, and B. T. Rouse. 2004. Herpetic eye disease: immunopathogenesis and therapeutic measures. Expert Rev. Mol. Med. 2004:1-14.
15. Deshpande, S., M. Zheng, S. Lee, K. Banerjee, S. Gangappa, U. Kumaraguru, and B. T. Rouse. 2001. Bystander activation involving T lymphocytes in herpetic stromal keratitis. J. Immunol. 167:2902-2910.
16. Finberg, R. W., D. M. Knipe, and E. A. Kurt-Jones. 2005. Herpes simplex virus and Toll-like receptors. Viral Immunol. 18:457-465.
17. Gil, M. L., and D. Gozalbo. 2006. TLR2, but not TLR4, triggers cytokine production by murine cells in response to Candida albicans yeasts and hyphae. Microbes Infect. 8:2299-2304.
18. Kaisho, T., K. Hoshino, T. Iwabe, O. Takeuchi, T. Yasui, and S. Akira. 2002. Endotoxin can induce MyD88-deficient dendritic cells to support T(h)2 cell differentiation. Int. Immunol. 14:695-700.
19. Kennedy, P. G., and A. Chaudhuri. 2002. Herpes simplex encephalitis. J. Neurol. Neurosurg. Psych. 73:237-238.
20. Kim, B., S. Lee, S. Suvas, and B. T. Rouse. 2005. Application of plasmid DNA encoding IL-18 diminishes development of herpetic stromal keratitis by antiangiogenic effects. J. Immunol. 175:509-516.
21. Kim, B., P. P. Sarangi, Y. Lee, S. D. Kaistha, S. Lee, and B. T. Rouse. 2006. Depletion of MCP-1 increases development of herpetic stromal keratitis by innate immune modulation. J. Leukoc. Biol. 80:1405-1415.
22. Kim, B., Q. Tang, P. S. Biswas, J. Xu, R. M. Schiffelers, F. Y. Xie, A. M. Ansari, P. V. Scaria, M. C. Woodle, P. Lu, and B. T. Rouse. 2004. Inhibition of ocular angiogenesis by siRNA targeting vascular endothelial growth factor pathway genes: therapeutic strategy for herpetic stromal keratitis. Am. J. Pathol. 165:2177-2185.
23. Krug, A., G. D. Luker, W. Barchet, D. A. Leib, S. Akira, and M. Colonna. 2004. Herpes simplex virus type 1 activates murine natural interferon-producing cells through Toll-like receptor 9. Blood 103:1433-1437.
24. Kurt-Jones, E. A., M. Chan, S. Zhou, J. Wang, G. Reed, R. Bronson, M. M. Arnold, D. M. Knipe, and R. W. Finberg. 2004. Herpes simplex virus 1 interaction with Toll-like receptor 2 contributes to lethal encephalitis. Proc. Natl. Acad. Sci. USA 101:1315-1320.
25. Kurt-Jones, E. A., L. Popova, L. Kwinn, L. M. Haynes, L. P. Jones, R. A. Tripp, E. E. Walsh, M. W. Freeman, D. T. Golenbock, L. J. Anderson, and R. W. Finberg. 2000. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat. Immunol. 1:398-401.
26. Kwan, W. H., C. Boix, N. Gougelet, W. H. Fridman, and C. G. Mueller. 2007. LPS induces rapid IL-10 release by M-CSF-conditioned tolerogenic dendritic cell precursors. J. Leukoc. Biol. 82:133-141.
27. Liu, T., Q. Tang, and R. L. Hendricks. 1996. Inflammatory infiltration of the trigeminal ganglion after herpes simplex virus type 1 corneal infection. J. Virol. 70:264-271.
28. Lund, J., A. Sato, S. Akira, R. Medzhitov, and A. Iwasaki. 2003. Toll-like receptor 9-mediated recognition of herpes simplex virus-2 by plasmacytoid dendritic cells. J. Exp. Med. 198:513-520.
29. Mansur, D. S., E. G. Kroon, M. L. Nogueira, R. M. Arantes, S. C. Rodrigues, S. Akira, R. T. Gazzinelli, and M. A. Campos. 2005. Lethal encephalitis in myeloid differentiation factor 88-deficient mice infected with herpes simplex virus 1. Am. J. Pathol. 166:1419-1426.
30. McGill, J., and G. M. Scott. 1985. Viral keratitis. Br. Med. Bull. 41:351-356.
31. Melchjorsen, J., L. N. Sorensen, and S. R. Paludan. 2003. Expression and function of chemokines during viral infections: from molecular mechanisms to in vivo function. J. Leukoc. Biol. 74:331-343.
32. Minagawa, H., S. Sakuma, S. Mohri, R. Mori, and T. Watanabe. 1988. Herpes simplex virus type 1 infection in mice with severe combined immunodeficiency (SCID). Arch. Virol. 103:73-82.
33. Mitchell, B. M., and J. G. Stevens. 1996. Neuroinvasive properties of herpes simplex virus type 1 glycoprotein variants are controlled by the immune response. J. Immunol. 156:246-255.
34. Mitsunari, M., S. Yoshida, T. Shoji, S. Tsukihara, T. Iwabe, T. Harada, and N. Terakawa. 2006. Macrophage-activating lipopeptide-2 induces cyclooxygenase-2 and prostaglandin E(2) via Toll-like receptor 2 in human placental trophoblast cells. J. Reprod. Immunol. 72:46-59.
35. Mogensen, T. H., and S. R. Paludan. 2005. Reading the viral signature by Toll-like receptors and other pattern recognition receptors. J. Mol. Med. 83:180-192.
36. O'Neill, L. A. 2004. Immunology. After the Toll rush. Science 303:1481-1482.
37. Spear, P. G., and B. Roizman. 1972. Proteins specified by herpes simplex virus. V. Purification and structural proteins of the herpesvirion. J. Virol. 9:143-159.
38. Thomas, J., S. Gangappa, S. Kanangat, and B. T. Rouse. 1997. On the essential involvement of neutrophils in the immunopathologic disease: herpetic stromal keratitis. J. Immunol. 158:1383-1391.
39. van Eden, W., G. Wick, S. Albani, and I. Cohen. 21 June 2007. Stress, heat shock proteins, and autoimmunity: how immune responses to heat shock proteins are to be used for the control of chronic inflammatory diseases. Ann. N. Y. Acad. Sci. [Epub ahead of print.] http://www.annalsnyas.org/cgi/ rapidpdf/annals.1391.020v1.
40. Villamon, E., P. Roig, M. L. Gil, and D. Gozalbo. 2005. Toll-like receptor 2 mediates prostaglandin E(2) production in murine peritoneal macrophages and splenocytes in response to Candida albicans. Res. Microbiol. 156:115-118.
41. Zheng, M., S. Deshpande, S. Lee, N. Ferrara, and B. T. Rouse. 2001. Contribution of vascular endothelial growth factor in the neovascularization process during the pathogenesis of herpetic stromal keratitis. J. Virol. 75:9828-9835.
42. Zheng, M., D. M. Klinman, M. Gierynska, and B. T. Rouse. 2002. DNA containing CpG motifs induces angiogenesis. Proc. Natl. Acad. Sci. USA 99:8944-8949.
43. Zhou, S., E. A. Kurt-Jones, L. Mandell, A. Cerny, M. Chan, D. T. Golenbock, and R. W. Finberg. 2005. MyD88 is critical for the development of innate and adaptive immunity during acute lymphocytic choriomeningitis virus infection. Eur. J. Immunol. 35:822-830.